Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Geller

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Nature Microbiology|August 31, 2016
Highly heterogeneous mutation rates in the hepatitis C virus genomeRon Geller, Úrsula Estada, Joan B Peris, et al.
Communications Biology|November 17, 2025
The sequence and structural integrity of the SARS-CoV-2 Spike protein transmembrane domain is crucial for viral entryJuan Ortiz-Mateu, Diego Belda, Ana Isabel Avilés-Alía, et al.
Journal of Medical Virology|July 5, 2023
Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individualsEliseo Albert, Daniel Fernández-Soto, Estela Giménez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 6, 2021
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassaysArantxa Valdivia, Ignacio Torres, Víctor Latorre, et al.
ACS Omega|September 15, 2025
Exploring SARS-CoV‑2 Spike RBD Pockets as Targets for Generic Drugs: A Combined Computational, Biophysical, and Biological ApproachJavier García-Marín, Clara Francés-Gómez, Alicia Forcada-Nadal, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2012
Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjectsCarmel T Chan, Robert E Reeves, Ron Geller, et al.
Cancers|December 30, 2025
The Rise of Fine-Tuned CAR-Based Therapies Against Acute Myeloid LeukemiaAlejandro Segura Tudela, Ron Geller, Bruno Paiva, et al.
Journal of Medical Virology|January 15, 2025
Estimating SARS-CoV-2 Omicron XBB.1.5 Spike-Directed Functional Antibody Levels From an Anti-Receptor Binding Domain Wuhan-Hu-1-Based Commercial Immunoassay ResultsÁngela Sánchez-Simarro, Enric Cuevas-Ferrando, Daniel Fernández-Soto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 4, 2020
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patientsRoberto Gozalbo-Rovira, Estela Gimenez, Víctor Latorre, et al.
Virus Evolution|May 1, 2025
Genome data artifacts and functional studies of deletion repair in the BA.1 SARS-CoV-2 spike proteinMiguel Álvarez-Herrera, Paula Ruiz-Rodriguez, Beatriz Navarro-Domínguez, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Nature Microbiology|August 31, 2016
Highly heterogeneous mutation rates in the hepatitis C virus genomeRon Geller, Úrsula Estada, Joan B Peris, et al.
Communications Biology|November 17, 2025
The sequence and structural integrity of the SARS-CoV-2 Spike protein transmembrane domain is crucial for viral entryJuan Ortiz-Mateu, Diego Belda, Ana Isabel Avilés-Alía, et al.
Journal of Medical Virology|July 5, 2023
Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individualsEliseo Albert, Daniel Fernández-Soto, Estela Giménez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 6, 2021
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassaysArantxa Valdivia, Ignacio Torres, Víctor Latorre, et al.
ACS Omega|September 15, 2025
Exploring SARS-CoV‑2 Spike RBD Pockets as Targets for Generic Drugs: A Combined Computational, Biophysical, and Biological ApproachJavier García-Marín, Clara Francés-Gómez, Alicia Forcada-Nadal, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2012
Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjectsCarmel T Chan, Robert E Reeves, Ron Geller, et al.
Cancers|December 30, 2025
The Rise of Fine-Tuned CAR-Based Therapies Against Acute Myeloid LeukemiaAlejandro Segura Tudela, Ron Geller, Bruno Paiva, et al.
Journal of Medical Virology|January 15, 2025
Estimating SARS-CoV-2 Omicron XBB.1.5 Spike-Directed Functional Antibody Levels From an Anti-Receptor Binding Domain Wuhan-Hu-1-Based Commercial Immunoassay ResultsÁngela Sánchez-Simarro, Enric Cuevas-Ferrando, Daniel Fernández-Soto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 4, 2020
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patientsRoberto Gozalbo-Rovira, Estela Gimenez, Víctor Latorre, et al.
Virus Evolution|May 1, 2025
Genome data artifacts and functional studies of deletion repair in the BA.1 SARS-CoV-2 spike proteinMiguel Álvarez-Herrera, Paula Ruiz-Rodriguez, Beatriz Navarro-Domínguez, et al.
Pageof 6